MaxCyte, Inc.

NASDAQ:MXCT

3.79 (USD) • At close September 6, 2024
Bedrijfsnaam MaxCyte, Inc.
Symbool MXCT
Munteenheid USD
Prijs 3.79
Beurswaarde 398,288,106
Dividendpercentage 0%
52-weken bereik 2.45 - 5.545
Industrie Medical Devices
Sector Healthcare
CEO Mr. Douglas Arthur Doerfler
Website https://maxcyte.com

An error occurred while fetching data.

Over MaxCyte, Inc.

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic

Vergelijkbare Aandelen

Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc.

NRIX

23.33 USD

OptimizeRx Corporation logo

OptimizeRx Corporation

OPRX

7.54 USD

Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc.

JANX

41.26 USD

Seer, Inc. logo

Seer, Inc.

SEER

1.64 USD

Ocugen, Inc. logo

Ocugen, Inc.

OCGN

1.14 USD

AirSculpt Technologies, Inc. logo

AirSculpt Technologies, Inc.

AIRS

3.6 USD

PetMed Express, Inc. logo

PetMed Express, Inc.

PETS

3.29 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

34.03 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

9.47 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)